Victoria is continuing to lead the way in mRNA manufacturing with the government agreeing to an in-principle partnership with ground-breaking German biotechnology company BioNTech.
The developers of the Pfizer/BioNTech Covid-19 mRNA vaccine have chosen Victoria to establish their Asia-Pacific mRNA clinical research and development centre which will form part of BioNTech’s global network. The new facility will support researchers to translate their work into medical breakthroughs.
Treasurer Tim Pallas and Minister for Innovation, Medical Research and the Digital Economy Jaala Pulford today announced an in-principle partnership with BioNTech to establish a clinical scale mRNA manufacturing facility in Melbourne, with Victoria and BioNTech entering formal discussions to bring this world leading company into the State, an official press release said.
The arrangement would see BioNTech deliver next-generation mRNA therapeutics and vaccines for research and clinical trials, including infectious diseases, cancer medicines and personalised cancer treatments.
It also includes BioNTech establishing its Artificial Intelligence-driven early warning and identification technology, which can be used to detect future disease threats and rapidly develop new treatments and vaccines, at the Victorian site.
Founded in 2008 in Germany, BioNTech has become a world leader in mRNA research and in 2020 successfully developed the Pfizer/BioNTech vaccine for COVID-19.
The in-principle partnership follows the Australian Government, Moderna and Victorian Government partnership to set up an mRNA vaccine manufacturing facility at Monash University – helping protect Australians against future pandemics, supporting local industry and creating highly skilled jobs.
Victoria is Australia’s leader in pharmaceutical and biological manufacturing, responsible for nearly 60 per cent of Australia’s pharmaceutical exports – making it our highest value advanced manufactured export.
The Labor Government has invested $1.3 billion in medical research since 2014 and has helped create more than 100,000 direct and indirect full-time jobs in the state’s biotech sector.
The Indian Sun acknowledges the support of the Victorian Government.
Support independent community journalism. Support The Indian Sun.
Follow The Indian Sun on Twitter | Instagram | Facebook
Support Independent Community Journalism
Dear Reader,The Indian Sun exists for one reason: to tell stories that might otherwise go unheard.
We report on local councils, state politics, small businesses and cultural festivals. We focus on the Indian diaspora and the wider multicultural community with care, balance and accountability. We publish in print and online, send regular newsletters and produce video content. We also run media training programs to help community organisations share their own stories.
We operate independently.
Community journalism does not have the backing of large media corporations. Advertising revenue fluctuates. Platform algorithms change. Costs continue to rise. Yet the need for credible, grounded reporting in a multicultural Australia has never been greater.
When you support The Indian Sun, you support:
• Independent reporting on issues affecting migrant communities
• Coverage of local and state decisions that shape daily life
• A platform for small businesses and community groups
• Media training that builds skills within the community
• Journalism accountable to readers
We cannot cover everything, but we work to cover what matters.
If you value thoughtful reporting that reflects Australia’s diversity, we invite you to contribute. Every donation helps us maintain the quality and consistency of our work.
Please consider making a contribution today.
Thank you for your support.
The Indian Sun Team
